The molecular hallmark of CML is the BCR-ABL fusion, whereas for BCR-ABL-negative MPNs (PMF, PV, ET) common mutations include JAK2 V617F and those within CALR exon 9. Here, ABL1 is linked to acquired polycythemia vera.